Category Over-the-Counter Drugs

Axxess Pharma Receives Health Canada Approval to Sell High Potency Omega-3 Fish Oil Supplement Throughout Canada

Nov19

TORONTO, ON (Marketwired) 11/19/14 Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have now received Health Canada approval to sell their high potency Omega-3 fish oil supplement throughout Canada. The Omega-3 fish oil will be sold under […]

PURAMED BIOSCIENCE INC.

Nov19

The following discussion and analysis of the Company’s financial condition andplan of operations should be read and considered along with its condensedfinancial statements and related notes included in this Quarterly Report on Form10-Q. Various statements have been made in this Quarterly Report on Form 10-Qthat may constitute "forward-looking statements." Forward-looking statements mayalso be made in […]

Federal Regulators Announce the Recall of Mayhem Dietary Supplements After Laboratory Testing Reveals Undeclared Drugs, Parker Waichman LLP Comments

Nov19

Port Washington, New York (PRWEB) November 19, 2014 Parker Waichman LLP, a national law firm representing patients injured by drugs and medical devices comments on a recall of Mayhem dietary supplements, produced by Chaotic Labz of Atkins, Arkansas. The recalled supplements were recalled after distribution nationwide to online stores and nutritional supplement sellers. The recall […]

Bayer acquires OTC drug firm Dihon for $586 million [China Daily: Africa Weekly]

Nov18

Germany-based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan ($586 million), which will help it become the world’s largest non-prescription medicine group.Bayer will hold 100 percent of Dihon, which specializes in over-the-counter skin products and herbal […]

Bayer acquires OTC drug firm Dihon for $586 million [China Daily: US Edition]

Nov18

Germany-based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan ($586 million), which will help it become the world’s largest non-prescription medicine group.Bayer will hold 100 percent of Dihon, which specializes in over-the-counter skin products and herbal […]

Bayer acquires OTC drug firm Dihon for $586 million [China Daily: Hong Kong Edition]

Nov18

Germany-based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan ($586 million), which will help it become the world’s largest non-prescription medicine group.Bayer will hold 100 percent of Dihon, which specializes in over-the-counter skin products and herbal […]

Actavis To Acquire Allergan In $66 Bln Deal

Nov17

DUBLIN (dpa-AFX) – Specialty pharmaceutical company Actavis plc (ACT) agreed Monday to acquire botox maker Allergan, Inc. (AGN) in a cash and stock deal valued at about $219 per share or $66 billion.The deal will enable Allergan to fend off a hostile takeover bid from Canadian drug maker Valeant Pharmaceuticals, Inc. (VRX.TO, VRX), which is […]

New retrospective data showed empagliflozin reduced A1C, body weight and markers of abdominal fat in adults with type 2 diabetes

Nov17

RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 17, 2014 /PRNewswire/ Empagliflozin tablets reduced hemoglobin A1C (a measure of average blood sugar over the past two to three months), body weight and several markers of abdominal fat in adults with type 2 diabetes (T2D), according to a new retrospective analysis of clinical trial data presented on behalf of […]

Perrigo Company plc Announces Quarterly Dividend

Nov17

By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc (NYSE: PRGO;TASE) announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on November 28, 2014 (see also Pharmaceutical its beginnings as a packager of generic home remedies in […]

Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex 600mg Extended-Release Tablets

Nov17

By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc (NYSE: PRGO; TASE) announced that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States. The product will be packaged and marketed under store and proprietary brands and will be a high quality, […]